1	Abnormal	abnormal	_	_	_	_	_	_	_
2	T	t	_	_	_	_	_	_	_
3	lymphocyte	lymphocyte	_	_	_	_	_	_	_
4	development	development	_	_	_	_	_	_	_
5	induced	induce	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	targeted	target	_	_	_	_	_	_	_
8	overexpression	overexpression	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	IkappaB	IkappaB	_	_	_	_	_	_	_
11	alpha	alpha	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	role	role	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	thymic	thymic	_	_	_	_	_	_	_
5	maturation	maturation	_	_	_	_	_	_	_
6	for	for	_	_	_	_	_	_	_
7	factors	factor	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
11	family	family	_	_	_	_	_	_	_
12	has	have	_	_	_	_	_	_	_
13	long	long	_	_	_	_	_	_	_
14	been	be	_	_	_	_	_	_	_
15	suspected	suspect	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	but	but	_	_	_	_	_	_	_
18	not	not	_	_	_	_	_	_	_
19	yet	yet	_	_	_	_	_	_	_
20	proven	prove	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Transgenic	transgenic	_	_	_	_	_	_	_
2	mice	mouse	_	_	_	_	_	_	_
3	with	with	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	lymphocyte-specific	lymphocyte-specific	_	_	_	_	_	_	_
6	defect	defect	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
9	activation	activation	_	_	_	_	_	_	_
10	were	be	_	_	_	_	_	_	_
11	produced	produce	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	targeted	target	_	_	_	_	_	_	_
14	expression	expression	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	human	human	_	_	_	_	_	_	_
17	IkappaB	IkappaB	_	_	_	_	_	_	_
18	alpha	alpha	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	thymic	thymic	_	_	_	_	_	_	_
3	cellularity	cellularity	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	these	these	_	_	_	_	_	_	_
6	mice	mouse	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	significantly	significantly	_	_	_	_	_	_	_
9	decreased	decrease	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	proportion	proportion	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	mature	mature	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	TCRhigh	tcrhigh	_	_	_	_	_	_	_
7	thymocytes	thymocyte	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	alphabeta	alphabeta	_	_	_	_	_	_	_
11	lineage	lineage	_	_	_	_	_	_	_
12	was	be	_	_	_	_	_	_	_
13	reduced	reduce	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	remaining	remain	_	_	_	_	_	_	_
18	TCRhigh	tcrhigh	_	_	_	_	_	_	_
19	population	population	_	_	_	_	_	_	_
20	contained	contain	_	_	_	_	_	_	_
21	an	an	_	_	_	_	_	_	_
22	unusually	unusually	_	_	_	_	_	_	_
23	high	high	_	_	_	_	_	_	_
24	proportion	proportion	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	double-positive	double-positive	_	_	_	_	_	_	_
27	cells	cell	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	defect	defect	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	maturation	maturation	_	_	_	_	_	_	_
5	resulted	result	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	transgene	transgene	_	_	_	_	_	_	_
9	dose-dependent	dose-dependent	_	_	_	_	_	_	_
10	reduction	reduction	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	peripheral	peripheral	_	_	_	_	_	_	_
13	T	t	_	_	_	_	_	_	_
14	lymphocytes	lymphocyte	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	with	with	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	CD8	cd8	_	_	_	_	_	_	_
19	lineage	lineage	_	_	_	_	_	_	_
20	being	be	_	_	_	_	_	_	_
21	more	more	_	_	_	_	_	_	_
22	severely	severely	_	_	_	_	_	_	_
23	affected	affect	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	data	datum	_	_	_	_	_	_	_
3	provide	provide	_	_	_	_	_	_	_
4	direct	direct	_	_	_	_	_	_	_
5	evidence	evidence	_	_	_	_	_	_	_
6	for	for	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	involvement	involvement	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	NF-kappaB/Rel	NF-kappaB/Rel	_	_	_	_	_	_	_
11	family	family	_	_	_	_	_	_	_
12	proteins	protein	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	late	late	_	_	_	_	_	_	_
15	stages	stage	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	T	t	_	_	_	_	_	_	_
18	lymphocyte	lymphocyte	_	_	_	_	_	_	_
19	development	development	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	coincident	coincident	_	_	_	_	_	_	_
22	with	with	_	_	_	_	_	_	_
23	positive	positive	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	negative	negative	_	_	_	_	_	_	_
26	selection	selection	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

